These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37648575)

  • 1. Nurses' Attitudes Concerning Analgesia Administration for Pediatric Patients with Sickle Cell Disease in Jordan: A Cross-Sectional Study.
    Abdel Razeq NM; Ali RA; Aqel A; Pack-Mabien AV; Sabbah EA; Qadiri IA; Aldasoqi KY
    Pain Manag Nurs; 2024 Feb; 25(1):e29-e36. PubMed ID: 37648575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease.
    Beyer JE
    J Pain Symptom Manage; 2000 Jan; 19(1):63-72. PubMed ID: 10687328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.
    Gerardin M; Rousselet M; Couec ML; Masseau A; Guerlais M; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Victorri-Vigneau C
    PLoS One; 2021; 16(3):e0248649. PubMed ID: 33735176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M; Tobin JR; Billett C; Casella JF; Dover G
    Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
    Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
    Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.
    Horst J; Frei-Jones M; Deych E; Shannon W; Kharasch ED
    Pediatr Blood Cancer; 2016 Dec; 63(12):2123-2130. PubMed ID: 27572136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain management in children with sickle cell disease.
    Stinson J; Naser B
    Paediatr Drugs; 2003; 5(4):229-41. PubMed ID: 12662119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
    Galeotti C; Courtois E; Carbajal R
    Acta Paediatr; 2014 Dec; 103(12):e548-54. PubMed ID: 25130719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease.
    Glassberg JA; Tanabe P; Chow A; Harper K; Haywood C; DeBaun MR; Richardson LD
    Ann Emerg Med; 2013 Oct; 62(4):293-302.e10. PubMed ID: 23561465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
    Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL
    BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
    Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
    Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
    Kenney MO; Becerra B; Mallikarjunan A; Shah N; Smith WR
    Pain Med; 2022 Dec; 23(12):2042-2049. PubMed ID: 35708641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.